Skip to main content
. 2020 Mar 13;3(3):547–558. doi: 10.1021/acsptsci.0c00011

Figure 5.

Figure 5

Total, unencapsulated, and unbound PTX comparison. Presented is the total, unencapsulated, and unbound PTX concentration–time comparison for Taxol, Abraxane, and Genexol-PM treatment groups (mean ± SD, N = 8).